APP and myeloid sarcoma: On the other hand, in MS despite the augmented expression of the amyloid precursor protein (APP), reflecting axonal damage (55, 56), and the increased levels of soluble α-APP and β-APP, intermediate products of APP proteolysis, in brain lesions (57), amyloid plaques have not been found (58–62).